MAGEA4 and cancer: Here, we use cryoEM to investigate TCR-pMHC recognition, focusing on two μM affinity α/β TCRs derived from humanized mice30 that target a peptide epitope containing residues 230–239 from the cancer-testis antigen MAGEA4.